Skip to main content
. Author manuscript; available in PMC: 2016 May 31.
Published in final edited form as: Cell Rep. 2016 May 5;15(7):1394–1400. doi: 10.1016/j.celrep.2016.04.024

Table 1.

Hormones, Leucine Kinetics and Resting Energy Expenditure

Placebo Metformin
Basal Somatostatin Glucagon Basal Somatostatin Glucagon
Glucose (mg/dL) 108±3 103±7 b 214±8 c 93±3 a 85±10 a, b 212±10c
Glucagon (pg/mL) 90.7±10.0 54.3±7.5 b 157.1±7.7 c 119.1±13.5 60.2±6.9 b 156.6±11.5 c
Insulin (μU/mL) 13.2±1.4 0.53±0.06 b 5.4±1.4 c 11.4±1.5 a 0.46±0.05 b 4.7±0.5
C-peptide (nmol/L) 1.31±0.09 0.33±0.02 b 0.46±0.03 c 1.13±0.08 a 0.28±0.02a,b 0.38±0.03a,c
Leucine C Flux 95.0±4.2 89.6±3.5 b 85.5±4.0 c 93.0±1.7 90.2±2.0 b 87.6±2.4
Leucine Oxidation 19.9±1.2 16.5±1.2 b 23.7±1.7 c 18.3±0.8 16.4±0.7 19.8±1.3a,c
Leu Protein Synthesis 75.1±3.8 73.2±3.5 b 61.8±3.5 c 74.7±2.0 73.8±2.0 b 67.8±2.0a,c
Leucine N Flux 155.0±6.3 197.9±7.5 b 215.1±12.5 c 159.3±6.2 204.7±6.1 b 230.4±9.4c
Leucine Transamination 79.9±4.2 124.8±7.1 b 149.8±10.2 c 84.5±4.7 a 130.9±4.6 b 165.0±7.8 c
Leucine Reamination 60.0±4.2 108.3±4.2 b 126.1±10.0 c 66.3±4.7 a 114.5±4.6 b 145.2±7.3a,c
% Flux Oxidized 21.0±1.3 18.5±1.5 b 27.9±2.0 c 19.7±1.0 18.2±0.8 b 22.5±1.1a,c
REE (kcals/day) 1669±138 1682±122 1925±139 c 1727±103 1719±93 1858±97
RER 0.82±0.01 0.75±0.02 0.78±0.02 0.82±0.01 0.74±0.02 0.75±0.02
a

p<0.05 metformin vs. placebo;

b

p<0.05 somatostatin vs. basal;

c

p<0.05 glucagon vs. somatostatin.

Data expressed as μmol/kgFFM/hr for whole-body leucine kinetics. Data are represented mean ± SE